Physician profile
Edith Boyes
NPI 1881138345
$21,373.03
in general payments reported to CMS, 2019-2025
11 companies · $8,866 in 2025
The $8,866 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,599 · 2022: $1,350 · 2023: $5,516 · 2024: $4,043 · 2025: $8,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,944 · Travel and Lodging: $4,995 · Food and Beverage: $3,235 · Honoraria: $2,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,943.75 |
| Travel and Lodging | $4,995.25 |
| Food and Beverage | $3,235.10 |
| Honoraria | $2,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,604.45 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, 2nd Gen Centrimag Primary Console |
| Abiomed | $4,158.42 | 2022-2025 | Impella |
| Medtronic, INC. | $188.97 | 2022-2024 | |
| Astrazeneca Pharmaceuticals Lp | $111.41 | 2023-2025 | Wainua |
| Kestra Medical Technology Services, INC. | $81.38 | 2024-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.06 | 2021-2024 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $68.32 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.86 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.02 | 2023 | Camzyos |
| Scpharmaceuticals INC. | $19.29 | 2023 | |
| Livanova USA, INC. | $16.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Boyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.